Silver - Modern Poultry

Ceva producing aMPV experimental autogenous vaccine using US-origin isolate

Ceva Animal Health has started antigen production for an experimental autogenous vaccine to fight the emerging avian metapneumovirus (aMPV) disease.

Vaccine combination shows cross-protection for multiple IBV variants

Day-old birds immunized with vaccines for Georgia (GA) and Massachusetts (Mass) serotypes of infectious bronchitis virus (IBV) were shown to be protected against four other circulating IBV variants in a recent study.

UGA scientist: Day-length affects behavior, welfare of broilers

Light and dark cycles within a 24-hour period play a crucial role in maintaining physiological and behavioral rhythms in animals.

Clearer picture emerging on how to tackle aMPV outbreak in US poultry

Avian metapneumovirus (aMPV) has swept through production facilities across the US since its initial appearance in late 2023. aMPV infections can result in mass morbidity, significant egg drops and, in the most severe cases, mortalities.

MENU

Category: Silver

focus on:

Industry insights: